Signal2026-07-24
ClinicalTrials.gov

[PHASE1] A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Part of

Cancer Immunotherapy And Combination Strategies

Open primary sourceRead on Substack